New coronavirus variant may pose reinfection risk, plasma therapy may be rendered ineffective


The new coronavirus variants are causing jitters among scientists since recent studies have found that they pose a reinfection risk among those who have already recovered from coronavirus infection and that they may be strong enough to render plasma therapy virtually ineffective.

Scientists noted that as per earlier studies, those who recovered from COVID-19 have immunity for at least five to six months, said FoxNews. It was also rare for a re-infection to occur out of previous strains. However, the story is quite different with the new strains because there is a possible risk of contracting the virus once more.